💡 Did you know?
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
History
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
Nath Bio-Genes (India) Limited is an India-based company, which is engaged in the business of production, processing, and marketing of hybrid and GM Seeds. The Company has a product range of field crops, vegetable crops and plant nutrient supplements. The major processing…
Weekly engine runs — movement reflects the numbers, not analyst opinion.
A decent, slow-growing business, trading cheap versus its own history.
Nath Bio-Genes is scored on the general / industrial framework. It keeps a slim 9.2% of every rupee of sales as net profit. Cash conversion lags the reported profit (CFO/PAT -0.30×) — worth a closer look. Free cash flow is worth about -3.5% of its market value.
Over the last 3 years revenue compounded at 15%/yr and profit at 6%/yr. Book value has grown 6%/yr. Return on equity is a weak 5.3%.
At 7× earnings, the stock sits at the 2nd percentile of its own 3.6-year range — the cheap end of where it has historically traded. Today's price asks for only ~-6%/yr growth over a decade — undemanding expectations. The books come through clean — a forensic grade of A, and Altman puts distress risk in the safe zone.
A plain-English restatement of the figures on this page — rules-based, for education and research context, not investment advice or a recommendation.
| Ratio | Company | Sector | Read |
|---|---|---|---|
| P/E | 6.79 | — | — |
| P/B | 0.39 | — | — |
| EV/EBITDA | 5 | — | — |
| ROE | 5.32 | 14.7 | worse |
| ROCE | 6.87 | 12.12 | worse |
| ROA | 3.52 | 1.4 | better |
| Quick Ratio | 0.83 | — | — |
| Peer | P/E | P/B | ROE |
|---|---|---|---|
| Hindustan Unilever | 31.1 | 9.6 | 22.9% |
| ITC | 18.4 | 5.0 | 26.4% |
| Nestle India | 60.5 | 42.7 | 70.6% |
Revenue has grown every year across all 4 financial years shown. 14% CAGR over 3 years — steady double-digit compounder. Growth is accelerating — latest year outpaced the prior year's rate.
Revenue is outpacing profit (14% vs 6%) — costs are rising faster than the top line.
Operating margin has compressed from 12% to 10% — costs or competition are eating into profitability. Margins have declined for 3 consecutive years — watch for a structural cost problem.
ROE at 6% — modest; the capital isn't working hard. Low variance across years — a predictable business that earns steadily on its equity base.
4% EPS CAGR — this is the rate at which each share's claim on earnings is compounding.
1 of 4 years had negative operating cash flow — profitability on paper may not translate to cash. Financing outflows in consecutive years — balance-sheet discipline through debt repayment or dividends.
When operating cash keeps pace with reported profit, earnings are cash-backed; a persistent shortfall is a quality flag.
Revenue rose 512% sequentially — momentum is building. Wide quarterly swings (86% spread) — likely seasonality, lumpy orders, or project-based revenue. Run-rate stepping up — recent quarters average 239% above earlier ones.
1 of 4 quarters loss-making — quarterly profitability is uneven. Profit jumped 322700% QoQ — check if this is operating leverage or a one-off item.
How today's P/E compares to the stock's own historical range. Dashed line = the 3.6y median.
Promoters at 45.6% — dispersed ownership; institutional flows drive the stock.
Produced by a rules-based engine over licensed exchange fundamentals — every sentence above is derived from the numbers shown, no analyst or AI opinion involved. Education and research context, not investment advice. We are not SEBI-registered as an Investment Adviser or Research Analyst.